Analysis of the Efficacy of Irinotecan in the Second-line Treatment of Refractory and Relapsed Small Cell Lung Cancer

Analysis of the Efficacy of Irinotecan in the Second-line Treatment of Refractory and Relapsed Small Cell Lung Cancer

Background and objective Among malignant tumors, lung cancer has the highest mortality rate. Small cell lung cancer (SCLC) is a kind of malignant lung cancer. Its doubling time is very fast. Patients are prone to drug resistance during treatment, and their condition often deteriorates rapidly after...

Full description

Bibliographic Details
Main Authors: He XING, Jie ZHANG, Fengjuan GE, Xinhang YU, Huimin BIAN, Fuliang ZHANG, Jian FANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2021-03-01
Series:Chinese Journal of Lung Cancer
Subjects:
lung neoplasms
refractory relapse
irinotecan
drug resistance
analysis of curative effect
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2021.103.04

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2021.103.04

Similar Items